is 1.25 mg of semaglutide a lot Our wave revolutionary weight loss drugs can be miracle if we get it right Semaglutide, Wegovy & Ozempic: A

3 4 A diet based on whole foods, regular physical activity, and psychological support all have strong evidence for supporting both weight loss and mood

Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement

June 2, 2025 Early Defense Strategy Emerges in Vision Loss Cases Novo Nordisk is already telegraphing part of its defense strategy for the NAION lawsuits: blame the underlying health conditions

Funding This article was supported by Novo Nordisk, who was provided with the opportunity to perform a medical accuracy review